Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2008
10/08/2008CN101282966A Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
10/08/2008CN101282963A Pyrazole derivatives as therapeutic agents
10/08/2008CN101282960A RAF inhibitor compounds and methods
10/08/2008CN101282954A Therapeutic agents
10/08/2008CN101282953A Therapeutic agents
10/08/2008CN101282952A Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/08/2008CN101282951A N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/08/2008CN101282944A Crystalline rosuvastatin intermediate
10/08/2008CN101282939A Diacyl indazole derivatives as lipase and phospholipase inhibitors
10/08/2008CN101282761A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101282725A Diabetes-treating agent
10/08/2008CN101282721A Composition for relieving subjective symptoms of fatigue
10/08/2008CN101282720A Parenteral selenomethionine for production of selenium-rich foods
10/08/2008CN101280288A Space efficient microbial strain of 20th recoverable satellite, preparation and application thereof
10/08/2008CN101280287A Space efficient microbial strain of 21st recoverable satellite, preparation and application thereof
10/08/2008CN101280286A Space efficient microbial strain of 22nd recoverable satellite, preparation and application thereof
10/08/2008CN101280012A Exendin-4 active isomer and application thereof
10/08/2008CN101280009A Exendin4 polypeptide fragments
10/08/2008CN101279993A 3-aryl-8-hydroxychromone-7-O-alpha-D-arabinofuranoside compound, synthetic method and use thereof
10/08/2008CN101279955A N-substituted thiamorpholine derivate as DPP-IV inhibitor and medical use thereof
10/08/2008CN101279915A Substituted phenol and application thereof as receptor TR3 excitant
10/08/2008CN101279096A Pullulan polysaccharide Vc coating combination
10/08/2008CN101279076A Medicinal liquor for cleaning vascular lipids and preventing cerebrovascular disease
10/08/2008CN101279059A Chinese medicine prescription applied in diabetic and preparation method
10/08/2008CN101279055A Novel therapeutic use of ginseng and astragali pollen preparations and quality control method
10/08/2008CN101279038A Chinese medicine for treating diabetes
10/08/2008CN101279034A Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof
10/08/2008CN101279012A Chinese medicine tea for weight reduction, toxin elimination and beauty treatment and matching Chinese medicinal composition
10/08/2008CN101279011A Nutrition agent for quick recovery of physical strength
10/08/2008CN101279009A Chinese medicine powder for treating diabetic
10/08/2008CN101278999A Applications of Murraya jasminorage leaf total flavones in preparation of medicament for curing diabetes
10/08/2008CN101278993A Method for extracting triterpenes from jujube fruit
10/08/2008CN101278985A Pharmaceutical combination for preventing birth-defect and improving memory
10/08/2008CN101278984A Pharmaceutical combination for preventing birth-defect and improving memory
10/08/2008CN101278983A Pharmaceutical combination for preventing birth-defect and improving memory
10/08/2008CN101278977A Method for extracting main active components of mulberry leaf and application of its extract
10/08/2008CN101278974A Cinnamon saponins extract, preparation method and application thereof
10/08/2008CN101278970A Method for preparing Elsholtzia bodinieri flavonoid and applications
10/08/2008CN101278964A Pabala selenizing VE health products
10/08/2008CN101278961A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/08/2008CN101278945A Pearl vitamin E soft capsule
10/08/2008CN101278944A Application of eggs rich in vanadium and chromium and method for producing the same
10/08/2008CN101278940A Medicament composition for curing diabetic cardiovascular pathological changes and method of preparing the same
10/08/2008CN101278930A New purpose of brevifolin
10/08/2008CN101278922A Medicament composition capsule and method of preparing the same
10/08/2008CN101278919A Metformin hydrochloride and Glipizide sustained-release pellet and method of preparing the same
10/08/2008CN101278743A Silkworm pupa oil and extracting method and applications
10/08/2008CN100423781C Application of Resistin binding polypeptide for preparing medicine promoting insulin secretion
10/08/2008CN100423777C Glycoprotein compositions
10/08/2008CN100423759C Natural insulin revivification phenethy biguanide and its preparation
10/08/2008CN100423715C New pharmaceutical composition
10/07/2008US7433788 Crystallization of IGF-1
10/07/2008US7432392 Ester derivatives and medical use thereof
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432288 Pyrrole-2,5-dione derivatives as Liver X receptor modulators
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas
10/07/2008US7432240 Fumaric acid amides
10/07/2008US7432087 Beginning with diastereo-and enantioselective reduction of a keto ester to obtain the hydroxy ester; use in drug preparation
10/07/2008US7432059 Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal
10/07/2008US7431943 Controlled release and taste masking oral pharmaceutical compositions
10/07/2008CA2426009C Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
10/07/2008CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2305926C Stable crystalline salts of 5-methyltetrahydrofolic acid
10/07/2008CA2280715C Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp.infection
10/07/2008CA2181909C Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
10/02/2008WO2008118883A1 Administering antisense oligonucleotides complementary to human apolipoprotein b
10/02/2008WO2008118718A2 2-aminopyridine analogs as glucokinase activators
10/02/2008WO2008118011A1 A composition for the treatment of diabetes mellitus
10/02/2008WO2008118010A1 Composition for the treatment of diabetes mellitus and metabolic syndrome
10/02/2008WO2008117982A1 Heterocyclic carboxylic acid derivatives and pharmaceutical composition for inhibiting lipid accumulation containing same
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117815A1 Inhibitor for cell death caused by endoplasmic reticulum stress or oxidation stress
10/02/2008WO2008117814A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008WO2008117481A1 Skin preparation for external use and food and drink
10/02/2008WO2008116742A1 Aza-pyridopyrimidinone derivatives
10/02/2008WO2008116700A1 Probiotics for reduction of risk of obesity
10/02/2008WO2008116648A2 Novel glp-1 fusion peptides, their production and use
10/02/2008WO2008116602A1 Cosmetic preparations designed to reduce unsightly cellulite
10/02/2008WO2008116380A1 A vaccine preventing and/or treating autoimmune diseases
10/02/2008WO2008116293A1 Multivalent heterobifunctional polymers and methods of their use
10/02/2008WO2008099025A3 Body-weight maintenance and body composition
10/02/2008WO2008058127A3 Agonist trkb antibodies and uses thereof
10/02/2008WO2008021577A3 Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
10/02/2008WO2007143336A3 Use of ractopamine enantiomers
10/02/2008WO2007093806A8 Dissolution aids for oral peptide delivery comprising a biguanide
10/02/2008US20080242732 Administering pharmaceutical orally at dose-delivery rate sufficient to provide clinically effective blood level in portal vein, less than required for blood level in peripheral circulation to provide dose-delivery selective in liver
10/02/2008US20080242716 Ion Channel Modulators
10/02/2008US20080242711 Inhibitors of cholesterol ester transfer protein
10/02/2008US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
10/02/2008US20080242678 Use of Flibanserin in the Treatment of Obesity
10/02/2008US20080242629 Hybrid nucleic acids; controlling gene expression; metabolism disorders, obesity, diabetes
10/02/2008US20080242621 Reducing blood glucose; increase insulin sensitivity; antidiabetic agents
10/02/2008US20080242619 Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders
10/02/2008US20080242612 Suspension containing milk fat spheres; therapy for infant weight disease
10/02/2008US20080242609 Composition for the therapy of diabetes mellitus and adiposity
1 ... 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 ... 1298